Akira Miyajima
- Urology top 0.5%
- Urological Disorders and Treatments 35
- Cancer Research top 2%
-
- Prostate Cancer Treatment and Research 49
- Prostate Cancer Diagnosis and Treatment 46
- Renal cell carcinoma treatment 33
- Nephrology top 2%
- Surgery top 2%
- Bladder and Urothelial Cancer Treatments 70
- Urinary and Genital Oncology Studies 46
-
- Renal and related cancers 19
-
- Urologic and reproductive health conditions 18
- Co-authors
- Eiji KikuchiMototsugu OyaTakeo KosakaMasaru MuraiKen NakagawaJun NakashimaNobuyuki TanakaShuji Mikami
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (4 papers)The EMBO Journal (1 paper)
- Partner nations
- JapanUnited StatesGreece
In The Last Decade
Akira Miyajima
263 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 142
- Urology 502
- Cancer Research 737
- Pulmonary and Respiratory Medicine 1.6k
- Nephrology 304
- Surgery 1.7k
Countries citing papers authored by Akira Miyajima
This map shows the geographic impact of Akira Miyajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Miyajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Miyajima more than expected).
Fields of papers citing papers by Akira Miyajima
This network shows the impact of papers produced by Akira Miyajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Miyajima. The network helps show where Akira Miyajima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Akira Miyajima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 5 | |
| 10 | 2020 | 6 | |
| 11 | 上部尿路尿路上皮癌における赤血球蛋白質バンド4.1like5発現の予後的意義【Powered by NICT】 | 2017 | 1 |
| 12 | 2015 | 4 | |
| 13 | 2013 | 23 | |
| 14 | 2012 | 38 | |
| 15 | 2010 | 9 | |
| 16 | 2009 | 3 | |
| 17 | 2008 | 22 | |
| 18 | 2006 | 0 | |
| 19 | 2001 | 76 | |
| 20 | The value of serum carboxyterminal propeptide of type 1 procollagen in predicting bone metastases in prostate cancer. | 1997 | 13 |
About Akira Miyajima
Akira Miyajima is a scholar working on Urology, Pulmonary and Respiratory Medicine and Surgery, having authored 274 papers that have together received 5.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (70 papers), Prostate Cancer Treatment and Research (49 papers), Urinary and Genital Oncology Studies (46 papers), Prostate Cancer Diagnosis and Treatment (46 papers), Urological Disorders and Treatments (35 papers), Renal cell carcinoma treatment (33 papers), Renal and related cancers (19 papers) and Urologic and reproductive health conditions (18 papers). The work is most often cited by research in Urology (502 citations), Cancer Research (737 citations) and Pulmonary and Respiratory Medicine (1.6k citations). Akira Miyajima has collaborated with scholars based in Japan, United States and Greece. Frequent co-authors include Eiji Kikuchi, Mototsugu Oya, Takeo Kosaka, Masaru Murai, Ken Nakagawa, Jun Nakashima, Nobuyuki Tanaka, Shuji Mikami, Masamichi Hayakawa and Kazuhiro Matsumoto. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.